Implications of a bioresorbable vascular scaffold implantation on vessel wall strain of the treated and the adjacent segments

International Journal of Cardiovascular Imaging

Volumn 30, Issue 3, 2014, Pages 477-484

  Bourantas, Christos V ^a   Garcia Garcia, Hector M ^a   Campos, Carlos A M ^a   Zhang, Yao Jun ^a   Muramatsu, Takashi ^a   Morel, Marie Angèle ^a   Nakatani, Shimpei ^a   Gao, Xingyu ^b   Cho, Yun Kyeong ^a   Isibashi, Yuki ^a   Gijsen, Frank J H ^a   Onuma, Yoshinobu ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ABBOTT VASCULAR   (United States)

Author keywords

Bioresorbable vascular scaffold; Palpography; Vessel wall strain

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BIORESORBABLE SCAFFOLD; BIORESORBABLE VASCULAR SCAFFOLD; BLOOD VESSEL WALL; DIAGNOSIS; DRUG ELUTING STENT; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; METAL STENT; NEOINTIMA; PALPOGRAPHY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANGIOCARDIOGRAPHY; BIODEGRADABLE IMPLANT; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; IMAGE PROCESSING; MECHANICAL STRESS; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; STENT; SURGERY; TISSUE SCAFFOLD;

ABSORBABLE IMPLANTS; CORONARY ANGIOGRAPHY; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSTHESIS DESIGN; ROC CURVE; STENTS; STRESS, MECHANICAL; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84899072644     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-014-0373-4     Document Type: Article

References (26)

1. Schaar JA, Regar E, Mastik F et al (2004) Incidence of high-strain patterns in human coronary arteries: assessment with three-dimensional intravascular palpography and correlation with clinical presentation. Circulation 109(22):2716-2719 (Pubitemid 38737916)
2. Schaar JA, De Korte CL, Mastik F et al (2003) Characterizing vulnerable plaque features with intravascular elastography. Circulation 108(21):2636-2641 (Pubitemid 37466804)
3. de Korte CL, Sierevogel MJ, Mastik F et al (2002) Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation 105(14):1627-1630 (Pubitemid 34298602)
4. Brugaletta S, Garcia-Garcia HM, Serruys PW et al (2012) Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging 5(3Suppl):S19-S27
5. Serruys PW, Ormiston JA, Onuma Y et al (2009) Abioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373(9667):897-910
6. Brugaletta S, Gogas BD, Garcia-Garcia HM et al (2012) Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments. Circ J 76(7):1616-1623
7. Van Mieghem CA, McFadden EP, de Feyter PJ et al (2006) Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the integrated biomarker and imaging study (IBIS). J Am Coll Cardiol 47(6):1134-1142
8. Serruys PW, Garcia-Garcia HM, Buszman P et al (2008) Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 118(11):1172-1182
9. Wykrzykowska JJ, Diletti R, Gutierrez-Chico JL et al (2012) Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT). EuroIntervention 8(8):945-954
10. Serruys PW, Onuma Y, Ormiston JA et al (2010) Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation 122(22):2301-2312
11. Schaar JA, van der Steen AF, Mastik F et al (2006) Intravascular palpography for vulnerable plaque assessment. J Am Coll Cardiol 47(8 Suppl):C86-C91
12. Garcia-Garcia HM, Gonzalo N, Pawar R et al (2009) Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. EuroIntervention 4(4):443-448
13. Tanimoto S, Bruining N, van Domburg RT (2008) Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology. J Am Coll Cardiol 52(20):1616-1620
14. Gomez-Lara J, Brugaletta S, Diletti R et al (2011) A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. Eur Heart J 32(3):294-304
15. Serruys PW, Onuma Y, Dudek D et al (2011) Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 58(15):1578-1588
16. Brugaletta S, Radu MD, Garcia-Garcia HM et al (2012) Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Atherosclerosis 221(1):106-112
17. Onuma Y, Serruys PW, Perkins LE et al (2010) Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 122(22):2288-2300
18. Peng X, Haldar S, Deshpande S et al (2003) Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41(2):378-381 (Pubitemid 36204918)
19. Gupta V, Grande-Allen KJ (2006) Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc Res 72(3):375-383 (Pubitemid 44755053)
20. Schad JF, Meltzer KR, Hicks MR et al (2011) Cyclic strain upregulates VEGF and attenuates proliferation of vascular smooth muscle cells. Vasc Cell 3:21
21. Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364(3):226-235
22. Serruys PW, Garcia-Garcia HM, Onuma Y (2012) From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33(1):16-25
23. Bourantas CV, Farooq V, Zhang Y, et al. (2013) Circumferential distribution of the neointima at 6 months and 2 years follow-up after a bioresorbable vascular scaffold implantation. A substudy of the ABSORB Cohort B Clinical Trial EuroIntervention (In press)
24. Stone GW (2013) Rationale and design of PROSPECT II. 11 Vulnerable Plaque Meeting, Paris, France, 23-26 June 2013
25. Imoto K, Hiro T, Fujii T et al (2005) Longitudinal structural determinants of atherosclerotic plaque vulnerability: a computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging. J Am Coll Cardiol 46(8):1507-1515 (Pubitemid 41446187)
26. Kumar RK, Balakrishnan KR (2005) Influence of lumen shape and vessel geometry on plaque stresses: possible role in the increased vulnerability of a remodelled vessel and the "shoulder" of a plaque. Heart 91(11):1459-1465 (Pubitemid 41531826)